Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial
Angeline Ginzac, Emmanuelle Bourbouloux, Romain Rivoirard, Christelle Jouannaud, Marie-Odile Hager, Sophie Dubois, Fabrice Kwiatkowski, Ioana Molnar, Emilie Thivat, Xavier Durando · 2025
Read Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial by Angeline Ginzac, Emmanuelle Bourbouloux, Romain Rivoirard, Christelle Jouannaud, Marie-Odile Hager, Sophie Dubois, Fabrice Kwiatkowski, Ioana Molnar, Emilie Thivat, Xavier Durando (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12836914.txt.
Description
Angeline Ginzac and co-authors test nightly melatonin for life quality in older adults starting new cancer treatment, in a trial from two thousand twenty-five. One hundred twenty-three patients aged seventy and over joined a blind, dummy-controlled trial across centers. The dose ran for the first three months of a new treatment line.
The trial stopped early for futility, and only about three fifths of patients stuck to the plan. Life quality scores showed no gain for the melatonin group among those who complied. The dose proved safe in this older group. Urine data on melatonin breakdown in older cancer patients is a fresh by-product. Readers get a clean negative result that saves false hope.
Catalog record
| CREATOR | Angeline Ginzac, Emmanuelle Bourbouloux, Romain Rivoirard, Christelle Jouannaud, Marie-Odile Hager, Sophie Dubois, Fabrice Kwiatkowski, Ioana Molnar, Emilie Thivat, Xavier Durando |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |